Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Future Capital AG is a venture capital firm based in Hessen, Germany, established in the late 1990s. The firm focuses on investments in the life sciences and chemical sectors, particularly targeting early-stage and startup companies. With a fund size of $64 million, Future Capital AG has historically supported innovative companies in healthcare and biotechnology.
Although the firm has a long-standing presence in the venture capital space, reports indicate that it ceased making new investments in 2020. Future Capital AG was co-financed by Land Hessen and Sanofi-Aventis Deutschland GmbH, reflecting a strong public-private partnership aimed at fostering growth in the life sciences sector.
Despite its current inactivity in new investments, Future Capital AG remains a notable entity in the venture capital landscape, particularly for its past contributions to the biotech and healthcare industries.
Future Capital AG primarily invests in the life sciences and chemical industries, with a strong emphasis on healthcare, biotechnology, and digital health solutions. The firm targets early-stage and startup companies, providing them with capital, industry expertise, and access to a robust network. The investment strategy is centered around supporting innovative chemistry applications and digital health solutions that address pressing medical challenges.
The firm’s investment thesis highlights the importance of biotechnology in pharmaceuticals and diagnostics, as well as the personalization of treatments and performance-oriented health systems. Future Capital AG aims to turn research in life sciences and chemistry into commercially viable applications, primarily focusing on companies located in Hessen and across Europe.
Future Capital AG has a notable portfolio that includes several key companies in the life sciences and healthcare sectors:
These companies exemplify Future Capital AG's focus on innovative solutions within the healthcare and biotechnology sectors.
Christian Leikert — CEO / Vorstand. Leikert has a background with Creathor Ventures and currently leads Future Capital AG, focusing on strategic direction and investment decisions.
Ingmar Jung — Vorstandsvorsitzender / Vorstand. Jung serves as a current representative of the company, contributing to its governance and oversight.
Dr. Klaus Menken — Vorstand. Menken is also a current representative, involved in the firm's strategic initiatives.
Mathias Samson — Vorstand. Samson serves as a current representative, participating in the firm's decision-making processes.
As of 2020, Future Capital AG has ceased making new investments, as confirmed by the Hessen government participation report. This decision marks a significant shift in the firm's operational strategy.
Recent reports have mentioned Aircode as a potential investment, but its status remains uncertain due to conflicting information regarding new investments.
Future Capital AG's historical focus on life sciences and chemical sectors continues to be recognized, although the firm is currently inactive in terms of new funding opportunities.
What are Future Capital AG's investment criteria?
Future Capital AG primarily invests in early-stage and startup companies within the life sciences and chemical sectors, focusing on healthcare, biotechnology, and digital health solutions.
How can I pitch to Future Capital AG?
Currently, Future Capital AG is not accepting new investments, as they ceased making new investments in 2020. Therefore, there is no active pitch process.
What makes Future Capital AG different from other investors?
Future Capital AG has a strong emphasis on supporting companies in the life sciences and chemical sectors, leveraging its extensive industry expertise and network to assist portfolio companies.
What is the geographic focus of Future Capital AG?
The firm primarily focuses on investments in Hessen, Germany, and across Europe, particularly in the life sciences and chemical industries.
What is the fund size and check size of Future Capital AG?
Future Capital AG manages a fund size of $64 million, although specific check sizes for investments have not been disclosed.
What kind of support does Future Capital AG provide to its portfolio companies?
Future Capital AG adds value by providing financial support, access to a robust network, and industry expertise, helping startups navigate the complexities of the healthcare and life sciences sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.